Figure 9 | Scientific Reports

Figure 9

From: A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma

Figure 9

The correlation between the risk model and immune activity in ESCC patients. (A) The expression levels of immune cell infiltration in high-risk and low-risk groups. (B–D) Analysis of the association between the risk model and immune-related score. (E–L) Kaplan–Meier curves of OS in ESCC patients based on immune cells. ESCC esophageal squamous cell carcinoma; *p < 0.05; **p < 0.01; ***p < 0.001.

Back to article page